Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

Post by bball67on Mar 10, 2022 1:47pm
227 Views
Post# 34503757

Wreckless Accusations

Wreckless AccusationsBrought to you by King David. "This Company is committing fraud" and "insider trading". He concludes, from some misguided logic, a PR and the stock going down a penny and then up a penny. What the heck. Don't you need some kind of proof David to accuse the Company of such things? No you don't, you did it before. 

Maybe three months ago, David suggested that the three 2021 billionaire investors in Promis had excited their positions in Promis. They put in $27M and then they sold out their positions. This was totally false. This prompted Promis to have someone monitor the Stockhouse Bullboard. 

David will attack me personally as a response. He won't comment on his false allegations. Yes, I have been in the stock for 4+ years. Yes, I own almost 1.5M shares at .15 US. Yes, I have been disappointed in management, a lack of urgency and progress, Yes, I have incorrectly predicted faster progress and was way off. Yes, I made alot of money as a SRVP of a very successful public company. Yes, I have an eight figure net worth. Yes, my Promis investment is less that 2% of my net worth. Yes, I believe that this investment will be a grand slam home run. Did I forget anything David?
<< Previous
Bullboard Posts
Next >>